These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38943290)
1. Prevalence of cardiovascular implantable electronic devices in children with type 1 myotonic dystrophy. Meziab O; Seckeler MD; Scherer K; Barber BJ Muscle Nerve; 2024 Nov; 70(5):1077-1081. PubMed ID: 38943290 [TBL] [Abstract][Full Text] [Related]
2. Risk for Complications after Pacemaker or Cardioverter Defibrillator Implantations in Patients with Myotonic Dystrophy Type 1. Sochala M; Wahbi K; Sorbets E; Lazarus A; Bécane HM; Stojkovic T; Fayssoil A; Laforêt P; Béhin A; Sroussi M; Eymard B; Duboc D; Meune C J Neuromuscul Dis; 2017; 4(3):175-181. PubMed ID: 28598855 [TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution. Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452 [TBL] [Abstract][Full Text] [Related]
4. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. Bhakta D; Shen C; Kron J; Epstein AE; Pascuzzi RM; Groh WJ J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1369-75. PubMed ID: 22035077 [TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy type 1 in South Korea: a comprehensive analysis of cancer and comorbidity risks. Seo I; Park JM Neurol Sci; 2024 Sep; 45(9):4573-4581. PubMed ID: 38613590 [TBL] [Abstract][Full Text] [Related]
6. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. Dello Russo A; Mangiola F; Della Bella P; Nigro G; Melacini P; Bongiorni MG; Tondo C; Calò L; Messano L; Pace M; Pelargonio G; Casella M; Sanna T; Silvestri G; Modoni A; Zachara E; Moltrasio M; Morandi L; Nigro G; Politano L; Palladino A; Bellocci F J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):51-8. PubMed ID: 19708226 [TBL] [Abstract][Full Text] [Related]
7. Diabetes, metformin and cancer risk in myotonic dystrophy type I. Alsaggaf R; Pfeiffer RM; Wang Y; St George DMM; Zhan M; Wagner KR; Amr S; Greene MH; Gadalla SM Int J Cancer; 2020 Aug; 147(3):785-792. PubMed ID: 31749144 [TBL] [Abstract][Full Text] [Related]
8. The Effects of Cardiac Implantable Electronic Device Personal Protective Equipment Use in Patients with Pediatric and Adult Congenital Heart Disease. Kean KA; Fitzgerald DJ; Ayers MD; Kean AC Pediatr Cardiol; 2023 Dec; 44(8):1721-1725. PubMed ID: 37573512 [TBL] [Abstract][Full Text] [Related]
9. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II. Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162 [TBL] [Abstract][Full Text] [Related]
10. Multicenter retrospective evaluation of magnetic resonance imaging in pediatric and congenital heart disease patients with cardiac implantable electronic devices. Gakenheimer-Smith L; Ou Z; Kuang J; Moore JP; Burrows A; Kovach J; Dechert B; Beach CM; Ayers M; Tan RB; Mostafavifar M; Mah DY; Conner TM; Turpin S; Avasarala K; Shah MJ; Webster G; Posey J; Etheridge SP; Binka E; Niu M; Asaki SY; Lambert LM; Pilcher TA Heart Rhythm; 2023 Dec; 20(12):1752-1758. PubMed ID: 37648183 [TBL] [Abstract][Full Text] [Related]
11. Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation. Russo V; Papa AA; Rago A; Ciardiello C; Martino AM; Stazi A; Golino P; Calò L; Nigro G Europace; 2022 Jul; 24(7):1148-1155. PubMed ID: 35861549 [TBL] [Abstract][Full Text] [Related]
12. Myotonic dystrophy type 1 and high ventricular vulnerability at the electrophysiological evaluation: ICD yes or not? Sirico G; Montisci A; Secchi F; Mantica M Acta Myol; 2020 Mar; 39(1):32-35. PubMed ID: 32607478 [TBL] [Abstract][Full Text] [Related]
13. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients. ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL Heart Rhythm; 2021 Nov; 18(11):1888-1924. PubMed ID: 34363988 [TBL] [Abstract][Full Text] [Related]
14. Sudden Death in Patients With Cardiac Implantable Electronic Devices. Tseng ZH; Hayward RM; Clark NM; Mulvanny CG; Colburn BJ; Ursell PC; Olgin JE; Hart AP; Moffatt E JAMA Intern Med; 2015 Aug; 175(8):1342-50. PubMed ID: 26098676 [TBL] [Abstract][Full Text] [Related]
16. Trends in cardiac implantable electronic device utilization in adults with congenital heart disease: a US nationwide analysis. Bhalla JS; Majmundar M; Patel KN; Deshmukh AJ; Connolly HM; Chirac A; Egbe AC; Miranda WR; Madhavan M J Interv Card Electrophysiol; 2024 Mar; 67(2):319-328. PubMed ID: 37392273 [TBL] [Abstract][Full Text] [Related]
17. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL JACC Clin Electrophysiol; 2021 Nov; 7(11):1437-1472. PubMed ID: 34794667 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of myotonic dystrophy type 1 in adults in western Sweden. Lindberg C; Bjerkne F Neuromuscul Disord; 2017 Feb; 27(2):159-162. PubMed ID: 28082207 [TBL] [Abstract][Full Text] [Related]
20. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients. Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Von Bergen NH; Wackel PL; Cardiol Young; 2021 Nov; 31(11):1738-1769. PubMed ID: 34338183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]